Market Place
Sourcing Support
All News #Library
Biotech
Cartherics And Catalent Expand Commercial License Agreement
09 Apr 2026 //
PHARMIWEB
GelMEDIX Partners with Catalent to Vision-Restoring Cell Therapy
15 Mar 2026 //
INDPHARMAPOST
Catalent, Gelmedix Partner For Global iPSC Cell Therapy
11 Mar 2026 //
PHARMIWEB
Catalent Moves to Wind Down Operations at EU Cell Therapy Hub
27 Jan 2026 //
FIERCE PHARMA
SmartCella, Catalent Sign GMP iPSC License Agreement
12 Jan 2026 //
BUSINESSWIRE
Lisata Therapeutics Showcases Certepetide Preclinical Data
04 Nov 2025 //
GLOBENEWSWIRE
Catalent Showcases Smartag ADC Pipeline At World ADC San Diego
04 Nov 2025 //
BUSINESSWIRE
Lisata & Catalent Announce Global ADC License Agreement
08 Oct 2025 //
GLOBENEWSWIRE
GenSight Biologics Reaches Milestone in Partnership with Catalent
26 Jun 2025 //
BUSINESSWIRE
Silexion Collaborates with Catalent on siRNA Development
23 Apr 2025 //
GLOBENEWSWIRE
Catalent to Support Galapagos’ Decentralized CAR-T Therapy Trials
21 Jan 2025 //
CONTRACTPHARMA
IsomAb Announces Strategic Collaboration with Catalent
28 Oct 2024 //
PRESS RELEASE
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
11 Oct 2024 //
BIOSPACE
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
17 May 2024 //
PRESS RELEASE
Catalent`s sales continue to be plagued by low COVID demand
09 Feb 2024 //
FIERCE PHARMA
Catalent`s stock down after Sarepta’s PhIII Duchenne study misses endpoint
31 Oct 2023 //
ENDPTS
Catalent poaches Lonza`s David McErlane to head up biologics
18 Sep 2023 //
FIERCE PHARMA
Sarepta`s gene therapy to be manufactured at Catalent plant
23 Jun 2023 //
ENDPTS
Catalent expands its biologics services platform after setbacks
07 Jun 2023 //
FIERCE PHARMA
Catalent to Present on Integrated UpTempo? Gene Therapy Development Platform
16 May 2023 //
PRESS RELEASE
Catalent Licenses Formulation Technology to Deliver High-Concentration Biologics
24 Mar 2023 //
CONTRACT PHARMA
Catalent Expands UpTempo AAV Platform for Development of Gene Therapies
09 Mar 2023 //
PRESS RELEASE
Catalent Opens Manufacturing Facility for Cell Therapies
30 Jan 2023 //
CONTRACT PHARMA
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility
26 Jan 2023 //
PRESS RELEASE
Catalent Appoints Ricardo Zayas SVP of Biologics North America Ops
17 Jan 2023 //
CONTRACT PHARMA
Sarepta and Catalent Expand Partnership DMD Gene Therapy Candidate
05 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.